VEEM FY26 slides: transition year shows H2 recovery momentum
VEEM FY26 slides: transition year shows H2 recovery momentum
Day: August 27, 2026
Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
“AI has reached its inflection point. It’s doing useful work. Its tokens are productive and profitable. Now, compute is revenue,” Nvidia Chief Executive Jensen Huang said.
DUG FY26 slides: record revenue, margin gains amid market skepticism
DUG FY26 slides: record revenue, margin gains amid market skepticism
Mpm Bioventures sells $461,545 in Entrada Therapeutics stock
Mpm Bioventures sells $461,545 in Entrada Therapeutics stock
Thinking Machines Lab cofounder Barret Zoph joins Google
Zoph will join Google’s DeepMind as Vice President of Research after serving as Vice President of Research at OpenAI.
Mpm Bioventures 2018 sells $461,545 of Entrada Therapeutics stock
Mpm Bioventures 2018 sells $461,545 of Entrada Therapeutics stock
Earnings call transcript: Credit Clear lifts FY2026 profit as U.K. push grows
Earnings call transcript: Credit Clear lifts FY2026 profit as U.K. push grows
Earnings call transcript: Sunny Optical H1 2026 profit rises, shares gain 5.2%
Earnings call transcript: Sunny Optical H1 2026 profit rises, shares gain 5.2%
Augmont Enterprises IPO allotment today; GMP at 40% hints at strong listing. Here’s how to check status
Following the allotment, shares for successful applicants are expected to be credited to their demat accounts ahead of the company’s market debut. Augmont Enterprises is scheduled to list on both the BSE and NSE on August 31, 2026.
Asian chip stocks mixed after Nvidia results as outlook diverges
Asian chip stocks mixed after Nvidia results as outlook diverges